OS THERAPIES INCORPORATED (OSTX) Operating cash flow 2023–2025
OS THERAPIES INCORPORATED (OSTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$14.2MFY2025 · since FY2023: -$3.0M → -$14.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$14.2M | -95.5% |
| FY2024 | -$7.3M | -142.2% |
| FY2023 | -$3.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More OSTX financial trends
OSTX RevenueOSTX Net incomeOSTX Net marginOSTX Gross profitOSTX Gross marginOSTX Operating incomeOSTX Operating marginOSTX Free cash flowOSTX Capital expendituresOSTX Return on equityOSTX Stock buybacksOSTX Dividends paidOSTX Total assetsOSTX Total liabilitiesOSTX Shareholders’ equityOSTX overview →